RPG Life Sciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

13.23

13.23

13.23

13.23

13.23

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

294.37

242.54

203.22

163.34

147.27

Loan funds

Secured loans

0.01

0.29

1.26

6.64

35.62

Unsecured loans

-

-

-

-

-

Total

307.61

256.06

217.71

183.21

196.12

Uses of funds

Fixed assets

Gross block

176.14

149.29

150.19

150.54

146.06

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

51.88

45.58

36.89

27.65

18.42

Net block

124.26

103.71

113.30

122.89

127.64

Capital work-in-progress

25.44

31.06

11.77

9.98

17.17

Investments

58.43

-

-

-

-

Net current assets

Current assets, loans & advances

211.22

209.84

178.32

133.86

106.43

Less : current liabilities & provisions

111.74

88.55

85.68

83.52

55.12

Total net current assets

99.48

121.29

92.64

50.34

51.31

Miscellaneous expenses not written

-

-

-

-

-

Total

307.61

256.06

217.71

183.21

196.12

Notes:

Book value of unquoted investments

58.43

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

33.52

15.12

16.98

14.20

11.73

Number of equity sharesoutstanding (Lacs)

165.39

165.39

165.39

165.39

165.39